Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding

Scientific Reports

Volumn 4, Issue , 2014, Pages

  He, Linling ^a   Sok, Devin ^a,b   Azadnia, Parisa ^a   Hsueh, Jessica ^a   Landais, Elise ^a   Simek, Melissa ^b   Koff, Wayne C ^b   Poignard, Pascal ^a,b   Burton, Dennis R ^a,b,c   Zhu, Jiang ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; NEUTRALIZING ANTIBODY;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CLASSIFICATION; DNA BARCODING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYLOGENY; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY; SOMATIC HYPERMUTATION; STANDARDS;

ANTIBODIES; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; B-LYMPHOCYTES; DNA BARCODING, TAXONOMIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; PHYLOGENY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84961289824     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06778     Document Type: Article

References (46)

1. Mardis, E. R. The impact of next-generation sequencing technology on genetics. Trends Genet. 24, 133-141, doi:10.1016/j.tig.2007.12.007 (2008).
2. Mardis, E. R. Next-generation DNA sequencing methods. Annu. Rev. Genom. Hum. Genet. 9, 387-402, doi:10.1146/annurev.genom.9.081307.164359 (2008).
3. Metzker, M. L. Sequencing technologies - the next generation. Nat. Rev. Genet. 11, 31-46, doi:10.1038/nrg2626 (2010).
4. Shendure, J. & Ji, H. Next-generation DNA sequencing. Nat. Biotechnol. 26, 1135-1145, doi:10.1038/nbt1486 (2008).
5. Reddy, S. T. & Georgiou, G. Systems analysis of adaptive immunity by utilization of high-throughput technologies. Curr. Opin. Biotechnol. 22, 584-589, doi:10.1016/j.copbio.2011.04.015 (2011).
6. Fischer, N. Sequencing antibody repertoires The next generation. Mabs 3, 17-20, doi:10.4161/mabs.3.1.14169 (2011).
7. Georgiou, G. et al. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat. Biotechnol. 32, 1-11, doi:10.1038/nbt.2782 (2014).
8. Weinstein, J. A., Jiang, N., White, R. A., III, Fisher, D. S. & Quake, S. R. High-Throughput Sequencing of the Zebrafish Antibody Repertoire. Science 324, 807-810, doi:10.1126/science.1170020 (2009).
9. Reddy, S. T. et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat. Biotechnol. 28, 965-969, doi:10.1038/nbt.1673 (2010).
10. Boyd, S. D. et al. Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing. Sci. Transl. Med. 1, 12ra23, doi:10.1126/scitranslmed.3000540 (2009).
11. Wu, X. et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing. Science 333, 1593-1602, doi:10.1126/science.1207532 (2011).
12. Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245-258, doi:10.1016/j.immuni.2013.04.012 (2013).
13. Zhu, J. et al. Somatic Populations of PGT135-137HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics. Front. Microbiol. 3, 315-315, doi:10.3389/fmicb.2012.00315 (2012).
14. Zhu, J. et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc. Natl. Acad. Sci. USA 110, 6470-6475, doi:10.1073/pnas.1219320110 (2013).
15. Zhu, J. et al. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc. Natl. Acad. Sci. USA 110, E4088-E4097, doi:10.1073/pnas.1306262110 (2013).
16. Sok, D. et al. The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies. PLoS Pathog. 9, e1003754, doi:10.1371/journal.ppat.1003754 (2013).
17. Huang, J. et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491, 406-412, doi:10.1038/nature11544 (2012).
18. Walker, L. M. et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target. Science 326, 285-289, doi:10.1126/science.1178746 (2009).
19. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470, doi:10.1038/nature10373 (2011).
20. Zhou, T. et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01. Science 329, 811-817, doi:10.1126/science.1192819 (2010).
21. Deng, W. et al. Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data. Bioinformatics 29, 2402-2409, doi:10.1093/bioinformatics/btt434 (2013).
22. Baum, P. D., Venturi, V. & Price, D. A. Wrestling with the repertoire: The promise and perils of next generation sequencing for antigen receptors. Eur. J. Immunol. 42, 2834-2839, doi:10.1002/eji.201242999 (2012).
23. Bolotin, D. A. et al. Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms. Eur. J. Immunol. 42, 3073-3083, doi:10.1002/eji.201242517 (2012).
24. Carlson, C. S. et al. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 4, 2680, doi:10.1038/ncomms3680 (2013).
25. Doria-Rose, N. A. et al. Developmental pathway for potent V1V2-directed HIVneutralizing antibodies. Nature 509, 55-62, doi:10.1038/nature13036 (2014).
26. Kwong, P. D., Mascola, J. R. & Nabel, G. J. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat. Rev. Immunol. 13, 693-701, doi:10.1038/nri3516 (2013).
27. Julien, J.-P. et al. Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans. PLoS Pathog. 9, e1003342, doi:10.1371/journal.ppat.1003342 (2013).
28. Barouch, D. H. et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224-228, doi:10.1038/nature12744 (2013).
29. Jardine, J. et al. Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors. Science 340, 711-716, doi:10.1126/science.1234150 (2013).
30. Haynes, B. F., Kelsoe, G., Harrison, S. C. & Kepler, T. B. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat. Biotechnol. 30, 423-433, doi:10.1038/nbt.2197 (2012).
31. Choi, N. M. et al. Deep Sequencing of the Murine Igh Repertoire Reveals Complex Regulation of Nonrandom V Gene Rearrangement Frequencies. J. Immunol. 191, 2393-2402, doi:10.4049/jimmunol.1301279 (2013).
32. Scheid, J. F. et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding. Science 333, 1633-1637, doi:10.1126/science.1207227 (2011).
33. Liao, H.-X. et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469-476, doi:10.1038/nature12053 (2013).
34. Shiroguchi, K., Jia, T. Z., Sims, P. A. & Xie, X. S. Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes. Proc. Natl. Acad. Sci. USA 109, 1347-1352, doi:10.1073/pnas.1118018109 (2012).
35. Jabara, C. B., Jones, C. D., Roach, J., Anderson, J. A. & Swanstrom, R. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc. Natl. Acad. Sci. USA 108, 20166-20171, doi:10.1073/pnas.1110064108 (2011).
36. Iwasaki, A. & Medzhitov, R. Regulation of Adaptive Immunity by the Innate Immune System. Science 327, 291-295, doi:10.1126/science.1183021 (2010).
37. Litman, G. W., Rast, J. P. & Fugmann, S. D. The origins of vertebrate adaptive immunity. Nat. Rev. Immunol. 10, 543-553, doi:10.1038/nri2807 (2010).
38. Koff, W. C. et al. Accelerating Next-Generation Vaccine Development for Global Disease Prevention. Science 340, 1232910, doi:10.1126/science.1232910 (2013).
39. Burton, D. R. et al. A Blueprint for HIV Vaccine Discovery. Cell Host Microbe 12, 396-407, doi:10.1016/j.chom.2012.09.008 (2012).
40. Mascola, J. R. & Montefiori, D. C. The Role of Antibodies in HIV Vaccines. Annu. Rev. Immunol. 28, 413-444, doi:10.1146/annurev-immunol-030409-101256 (2010).
41. Klein, F. et al. Antibodies in HIV-1 Vaccine Development and Therapy. Science 341, 1199-1204, doi:10.1126/science.1241144 (2013).
42. Parameswaran, P. et al. Convergent antibody signatures in human dengue. Cell Host Microbe 13, 691-700, doi:10.1016/j.chom.2013.05.008 (2013).
43. Simek, M. D. et al. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm. J. Virol. 83, 7337-7348, doi:10.1128/jvi.00110-09 (2009).
44. Li, M. et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125, doi:10.1128/jvi.79.16.10108-10125.2005 (2005).
45. Seaman, M. S. et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies. J. Virol. 84, 1439-1452, doi:10.1128/jvi.02108-09 (2010).
46. Wu, X. et al. Mechanismof Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment. J. Virol. 83, 10892-10907, doi:10.1128/jvi.01142-09 (2009).